
MacroGenics MGNX
$ 3.13
1.62%
Annual report 2025
added 03-09-2026
MacroGenics Total Inventories 2011-2026 | MGNX
Annual Total Inventories MacroGenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.91 M | - | 1.22 M | 1.45 M | 4.39 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.91 M | 1.22 M | 3.74 M |
Quarterly Total Inventories MacroGenics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.75 M | 9.28 M | 9.43 M | - | 3.24 M | 1.12 M | - | 1.22 M | 1.07 M | 1.44 M | 1.41 M | 1.45 M | 1.09 M | 2.95 M | 4.6 M | 4.39 M | 3.98 M | 6.48 M | 6.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.43 M | 1.07 M | 4 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerus Corporation
CERS
|
56.1 M | $ 2.72 | 33.99 % | $ 518 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 21.95 | -2.23 % | $ 3.64 B | ||
|
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B | ||
|
Caladrius Biosciences
CLBS
|
1.27 M | - | -16.75 % | $ 25.8 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
21.2 M | - | - | $ 2.18 B | ||
|
Dynavax Technologies Corporation
DVAX
|
70.1 M | - | - | $ 2.02 B | ||
|
Edesa Biotech
EDSA
|
224 K | $ 17.59 | -3.75 % | $ 56.2 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
1.56 M | - | -9.21 % | $ 2.55 M |